-

$undefined

N/A

(N/A)

Arcellx Inc NASDAQ:ACLX Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases.

Location: 25 West Watkins Mill Road, Suite A, MD, 20878, US | Website: https://arcellx.com | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

3.691B

Cash

516.7M

Avg Qtr Burn

-5.003M

Short % of Float

14.29%

Insider Ownership

12.75%

Institutional Own.

95.41%

Qtr Updated

06/30/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Anito-cel (anitocabtagene autoleucel)(CART-ddBCMA) Details Multiple myeloma, Cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ACLX-002 (ARC-SparX program) Details Myelodysplastic syndrome, Acute myeloid leukemia, Cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ACLX-001 (ARC-SparX program) Details Multiple myeloma, Cancer	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.